Paxlovid

Some docs reconsider Paxlovid use for mild COVID-19 cases … Department of Labor releases new guidance and FAQs on mental health leave … Redefine long COVID in seniors as a “geriatric syndrome,”...

Clinicians are writing 20,000 prescriptions for Paxlovid each day, helping to keep severe outcomes in check, the COVID-19 Response Coordinator said Wednesday.

Reports of symptoms returning in patients several days after completing the five-day regimen of Paxlovid

FDA official says “no evidence” second round of Paxlovid stops repeat symptoms, contradicting CEO … FDA planning for a “new normal”: annual COVID-19 and flu shots … Effect of COVID-19...

Paxlovid does not prevent COVID-19, new trial data show … Black and white patients have had similar risk of MS for decades, study finds … Parkinson’s drug hopeful found safe in early clinical trial...

Health officials are encouraging physicians to more frequently consider prescribing the oral antiviral now that it is no longer in short supply.

The agency is urging clinicians to consider the now readily available, recommended therapies such as Paxlovid as first-line COVID-19 treatments.

The WHO’s guidance comes as some patients and clinicians report recurring symptoms after patients successfully finish a course of Paxlovid.

HHS: Paxlovid to be repackaged for appropriate dosing in kidney patients … Study: Some 40% of community-dwelling seniors are inadequately hydrated … “Bivalent” booster offers better protection...

The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...